Evidence map›Paper›PMID 31584621›Full record

ArticleBioinformatics (Oxford, England)2020

Meltos: multi-sample tumor phylogeny reconstruction for structural variants.

Camir Ricketts, Daniel Seidman, Victoria Popic, Fereydoun Hormozdiari, Serafim Batzoglou, Iman Hajirasouliha

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. The Architecture of a Precision Oncology Platform.Advances in experimental medicine and biology · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Camir RickettsTri-Institutional Training Program in Computational Biology & Medicine, New York, NY 10065, USA.
Daniel SeidmanTri-Institutional Training Program in Computational Biology & Medicine, New York, NY 10065, USA.
Victoria PopicDepartment of Computer Science, Stanford University, Stanford, CA 94305, USA.
Fereydoun HormozdiariDepartment of Biochemistry and Molecular Medicine, MIND Institute and Genome Center, University of California, Davis, CA 95616, USA.
Serafim BatzoglouDepartment of Computer Science, Stanford University, Stanford, CA 94305, USA.
Iman HajirasoulihaDepartment of Physiology and Biophysics, Institute for Computational Biomedicine, Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine of Cornell University, New York, NY 10021, USA.
Stanford University · USTri-Institutional PhD Program in Chemical Biology · USCornell University · USUniversity of California, Davis · US

Funding

Tri-Institutional Training Program in Computational Biology & MedicineT32GM083937 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHRISTINI, DAVID J. · 2009 to 2018
$3.1M
Genomic Evolution of Breast CancerR01CA183904 · NCI · STANFORD UNIVERSITY · PI SIDOW, AREND, WEST, ROBERT B · 2015 to 2018
$2.6M
NCI NIH HHS R01 CA183904NIGMS NIH HHS T32 GM083937
6 · The paper itself

Abstract

motivationWe propose Meltos, a novel computational framework to address the challenging problem of building tumor phylogeny trees using somatic structural variants (SVs) among multiple samples. Meltos leverages the tumor phylogeny tree built on somatic single nucleotide variants (SNVs) to identify high confidence SVs and produce a comprehensive tumor lineage tree, using a novel optimization formulation. While we do not assume the evolutionary progression of SVs is necessarily the same as SNVs, we show that a tumor phylogeny tree using high-quality somatic SNVs can act as a guide for calling and assigning somatic SVs on a tree. Meltos utilizes multiple genomic read signals for potential SV breakpoints in whole genome sequencing data and proposes a probabilistic formulation for estimating variant allele fractions (VAFs) of SV events.

resultsIn order to assess the ability of Meltos to correctly refine SNV trees with SV information, we tested Meltos on two simulated datasets with five genomes in both. We also assessed Meltos on two real cancer datasets. We tested Meltos on multiple samples from a liposarcoma tumor and on a multi-sample breast cancer data (Yates et al., 2015), where the authors provide validated structural variation events together with deep, targeted sequencing for a collection of somatic SNVs. We show Meltos has the ability to place high confidence validated SV calls on a refined tumor phylogeny tree. We also showed the flexibility of Meltos to either estimate VAFs directly from genomic data or to use copy number corrected estimates. AVAILABILITY AND IMPLEMENTATION: Meltos is available at https://github.com/ih-lab/Meltos. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

NeoplasmsGenomeGenomicsGenomic Structural VariationHigh-Throughput Nucleotide SequencingHumansPhylogenySequence AnalysisSoftware

Identifiers

PMID31584621
PMCPMC8215921
OpenAlexW2977250149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.